Fibromyalgia Syndrome Clinical Trial
— KAFAOfficial title:
Kontrollierte Klinische Nicht-randomisierte Pilotstudie Zur Komplexen Āyurveda-Therapie Beim Fibromyalgiesyndrom im Vergleich Zur Konventionellen Standardbehandlung
Verified date | May 2013 |
Source | Charite University, Berlin, Germany |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ethics Committee |
Study type | Observational |
The aim of this study is to evaluate the effectiveness of an additive complex āyurvedic diagnosis and treatment compared to conventional standard care alone in stationary patients with Fibromyalgia Syndrome.
Status | Completed |
Enrollment | 31 |
Est. completion date | May 2013 |
Est. primary completion date | May 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - informed consent - age between 18 and 70 years - FMS according to current guidelines Exclusion Criteria: - change of pharmacological FMS treatment >= 6 weeks before inclusion - pregnancy or breat feeding - acute psychiatric condition - severe acute somatic disease - severechronic comorbidity - obesity WHO >= II degree - bloodcoagulation-disease - intake of opiods - current treatment with hyperthermia - simultaneous participant in other trial - praticipation in other trial during 6 month before inclusion |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Germany | Immanuel Hospital Berlin | Berlin |
Lead Sponsor | Collaborator |
---|---|
Andreas Michalsen | Dr.Heinz Horst Deichmann Foundation,Essen,Germany |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fibromyalgia Impact Questionnaire (FIQ) | Change in FIQ after completion of IPD-treatment | max. 3 weeks | No |
Secondary | Functional Hanover Questionnaire (FFBH) | max. 3 weeks | No | |
Secondary | State Trait Anxiety Inventory (STAI) | max. 3 weeks | No | |
Secondary | Profile of Mood States (POMS) | max. 3 weeks | No | |
Secondary | Short Form 36 Health Survey (SF-36) | max. 3 weeks | No | |
Secondary | VAS for pain | max 3 weeks | No | |
Secondary | Likert-Scales | max 3 weeks | No | |
Secondary | FIQ | 6 month | No | |
Secondary | FFBH, STAI, POMS, SF-36, VAS, Likert-Scales. | 6 month | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05933486 -
Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome
|
Phase 4 | |
Completed |
NCT01642810 -
Online Acceptance-based Behavioural Treatment for Fibromyalgia
|
Phase 3 | |
Completed |
NCT00757679 -
Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran
|
Phase 2 | |
Completed |
NCT00757731 -
FMS European Long-Term Study
|
Phase 3 | |
Completed |
NCT01968772 -
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia
|
N/A | |
Completed |
NCT00401830 -
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
|
Phase 2 | |
Completed |
NCT04517929 -
Effectiveness of Group Psychotherapy in Patients With Fibromyalgia Syndrome
|
N/A | |
Completed |
NCT06285045 -
Study on Roujin Formula in the Treatment of Fibromyalgia Syndrome With Blood Deficiency and Liver Depression
|
N/A | |
Completed |
NCT03844412 -
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
|
Phase 2 | |
Completed |
NCT02800720 -
Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome
|
N/A | |
Not yet recruiting |
NCT01465477 -
Influenza Vaccination in Fibromyalgia Patients
|
N/A | |
Completed |
NCT00528710 -
Efficacy of S-Adenosylmethionine in Fibromyalgia
|
Phase 2 | |
Completed |
NCT00447083 -
Benefits of Tanning in Fibromyalgia Patients
|
N/A | |
Not yet recruiting |
NCT06147882 -
The Effect of Positive Psychotherapy Based Psychoeducation on Pain Perception With Fibromyalgia Syndrome
|
N/A | |
Completed |
NCT05381012 -
Fibromyalgia Syndrome on Patients With Chronic Migraine
|
N/A | |
Completed |
NCT00464737 -
The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
|
Phase 2 | |
Completed |
NCT04426864 -
Efficacy of Different Types of Exercises in Women With Fibromyalgia Syndrome.
|
N/A | |
Completed |
NCT02881411 -
Self Soft Tissue Therapy for Fibromyalgia Syndrome
|
N/A | |
Not yet recruiting |
NCT01147263 -
Palpitations and Tachycardia in Fibromyalgia Syndrome
|
N/A | |
Completed |
NCT00222274 -
HRV Biofeedback in Fibromyalgia
|
N/A |